Beta-Adrenoceptor-medicated down-regulation of M2 muscarinic receptors: role of cyclic adenosine 5'-monophosphate-dependent protein kinase and protein kinase C

J Rousell, EB Haddad, JC Mak, BL Webb, MA Giembycz and PJ Barnes

Department of Thoracic Medicine, National Heart and Lung Institute, London, UK.

Stimulation of beta2-adrenoceptors with the selective beta2 agonist procaterol caused a biphasic decrease in cell surface M2 muscarinic receptor number in human embryonic lung 299 cells when measured with the hydrophilic antagonist [3H]N-methylscopolamine. In contrast, total muscarinic receptor number, measured with the lipophilic antagonist [3H]quinuclidinylbenzilate, decreased after only 24-hr treatments with procaterol. The loss in receptor number at 24 hr was mimicked with the use of forskolin and the cAMP analogue 8-bromo-cAMP, indicating a cAMP- mediated mechanism. Northern blot analysis showed a small and transient increase in m2-receptor mRNA levels up to 2 hr but no long term (24 hr) effect. Chronic (24 hr) treatment with 8-bromo-cAMP also had no effect on m2 muscarinic receptor mRNA, whereas forskolin caused a 50% reduction in the steady state levels of m2 mRNA that could be only partially blocked by the cAMP-dependent protein kinase inhibitor H-8 and the protein kinase C inhibitor GF 109203X. Procaterol-induced down- regulation of M2 receptors was fully blocked by N-[2- (methylamino)ethyl]-5'-isoquinoline-sulfonamide and 2-[1-(3- dimethylaminopropyl)-inol-3-yl]-3-(indol-3-yl)maleimide, implicating both of these kinases in the M2 muscarinic receptor down-regulation. Conversely, the forskolin- and 8-bromo-cAMP-induced down-regulation was only partially inhibited and unaffected by these inhibitors, respectively. In control cells and those treated with procaterol for < / = 2 hr, cAMP generation was significantly inhibited by carbachol. The inhibitory effect of carbachol was, however, lost after 24-hr exposure to procaterol. This desensitization was partially reversed by preincubations with H-8 and GF 109203X. Collectively, these results suggest that transregulation of M2 muscarinic receptors by beta2- adrenoceptor stimulation can be demonstrated at the protein level in human embryonic lung 299 cells. Furthermore, a role is suggested for cAMP-dependent kinase and PKC in M2 muscarinic receptor down-regulation and their functional desensitization.

Volume 49, Issue 4, pp. 629-635, 04/01/1996
Copyright © 1996 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				B. J. Proskocil and A. D. Fryer {beta}2-Agonist and Anticholinergic Drugs in the Treatment of Lung Disease Proceedings of the ATS, November 1, 2005; 2(4): 305 - 310. [Abstract] [Full Text] [PDF]

				J. Rousell, E.-B. Haddad, M. A. Lindsay, and P. J. Barnes Regulation of m2 Muscarinic Receptor Gene Expression by Platelet-Derived Growth Factor: Involvement of Extracellular Signal-Regulated Protein Kinases in the Down-Regulation Process Mol. Pharmacol., December 1, 1997; 52(6): 966 - 973. [Abstract] [Full Text]

				E. Gilad, H. Matzkin, and N. Zisapel Inactivation of Melatonin Receptors by Protein Kinase C in Human Prostate Epithelial Cells Endocrinology, October 1, 1997; 138(10): 4255 - 4261. [Abstract] [Full Text] [PDF]

				E.-B. Haddad, J. Rousell, M. A. Lindsay, and P. J. Barnes Synergy between Tumor Necrosis Factor alpha and Interleukin 1beta in Inducing Transcriptional Down-regulation of Muscarinic M2 Receptor Gene Expression. INVOLVEMENT OF PROTEIN KINASE A AND CERAMIDE PATHWAYS J. Biol. Chem., December 20, 1996; 271(51): 32586 - 32592. [Abstract] [Full Text] [PDF]

				M. C. Garofolo, F. J. Seidler, J. T. Auman, and T. A. Slotkin beta -Adrenergic modulation of muscarinic cholinergic receptor expression and function in developing heart Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2002; 282(5): R1356 - R1363. [Abstract] [Full Text] [PDF]